CDKN2A and neoplasm: In this study we investigate genomic patterns of tumor progression in a well-annotated clinical and molecular cohort of FP and FN RMS, showing that FP-RMS exhibit relatively stable genomes at relapse, while secondary alterations present at diagnosis, i.e., CDKN2A/B, MYCN, and CDK4, impacted survival.